Klebsiella trevisanii was first described in 1983 by Ferragut and his colleagues, who isolated it from soil and water (4) . In 1984, we reported two cases of colonization and one of septicemia due to this organism, all of which developed in the same intensive care unit at the Lyon Cardiological Hospital (5) . Following these initial observations and a further case of K. trevisanii septicemia, we attempted to determine the frequency with which K. trevisanii was being isolated from clinical specimens. We also sought possible reservoirs of the organism in the hospital environment. CASE REPORTS Case 1. A 69-year-old patient with mitral stenosis was hospitalized in August 1983 with infective endocarditis caused by a vitamin B6-deficient streptococcus strain, a condition which necessitated mitral valve replacement. Nine days postoperatively the patient became clinically septicemic. A gram-negative bacillus, initially identified as K. oxytoca but later found to be K. trevisanii, was isolated from three blood cultures. The patient recovered after treatment with a combination of cefotaxime and tobramycin.
Case 2. A 57-year-old patient developed pneumonia and became clinically septicemic 10 days after a coronary artery bypass graft. K. trevisanii was isolated from blood cultures and four consecutive tracheal aspirates. The patient recovered after treatment with ceftriaxone.
MATERIALS AND METHODS
Identification of bacteria. Clinical isolates of gram-negative bacilli from cardiological and neurological hospitals and the Edouafd Herriot Hospital (all in Lyon, France) were purified on bromocresol purple agar before initial identification using the API 20E gallery (Analytab Products, Inc., MontalieuVercieu, France). Isolates with the typical profile of K. oxytoca were then further identified by using the API 2OEC, a new gallery for the identification of coliform bacteria from the environment distributed by API Systems and API 147 assimilation galleries. The latter permits the study of carbon substrate assimilation by using 49 carbohydrates, 49 organic acids, and 49 ¶ amino acids (7). Motility was studied using peptone-water cultures.
Isolates were initially identified as K. trevisanii if they had the profile 1/777/473 in the API 20EC gallery, being distinguished from K. oxytoca by their failure'to acidify dulcitol and melezitose (8) . In the API 147 assimilation gallery K. * Corresponding author. trevisanii, unlike K. oxytoca, assimilates histamine but not meta-hydroxybenzoate.
Susceptibility to antibiotics, antiseptics, and disinfectants. The MICs of 12 antibiotics were determined using an agar dilution method (2) ( Table 1 ). Escherichia coli ATCC 25922 was used as the control organism. The MBCs of four antiseptics and disinfectants were determined as previously described (12) except for slight modifications. After three daily cultures of the strains on Letheen agar (Difco Laboratories, Detroit, Mich.), inocula were prepared in sterile distilled water containing 1 g of tryptone (Difco) and 8.5 g of NaCl per liter; 10 p,l of each inoculum was introduced into the holed cupules of a microtiter plate'(Dynatech Laboratories, Inc., France) (plate A). The different antiseptic dilutions (90 pul of each), prepared in sterile distilled water, were added to a microtiter plate (plate' B; Dynatech). At time t, inocula from plate A were transferred to plate B by capillary attraction; inocula and antiseptic dilutions were mixed by mechanical agitation. After 5 min of contact (t + 5) between bacteria and the antiseptics, 1.5 pul of the mixture was replicated onto the neutralizing agar (MIC 2000 Inoculator; Dynatech). After 24 h of incubation at 35°C, the MBCs were determined. Inocula were prepared to get 107 bacteria in the contact cupule. MBCs were recorded as giving a 105 reduction in the bacterial count. The agents tested were 5% aqueous chlorhexidine digluconate, 10% aqueous polyvinylpyrrolidone iodine (PVP-I), 1% iodine in alcohol, and aqueous sodiumn hypochlorite yielding 105.6 mg of free chlorine per liter. The control organism used was E. coli CNCM 854127.
Environmental samples. The following samples were taken in the rooms of 12 patients from whom K. trevisanii had been isolated: tap water and patients' drinking water; swabs of sink drain, soap, and facecloth; and swabs of artificial ventilator tubing where used. Fifteen 1-liter samples were also taken from the hospital water system. Water (10) suggested in 1979 that the main reservoir of clinically significant Klebsiella spp. in general was the human bacterial flora rather than the environment. The K. trevisanii isolates proved to have antibiotic susceptibility patterns similar to those of other Klebsiella spp. isolated in our hospital and elsewhere (9, 13) . They were uniformly resistant to ampicillit, ticarcillin, and rifampin. Two strains were resistant to cephalothin and one to piperacillin. The isolates' susceptibility to antiseptics and disinfectants was similar to that of other members of the family Enterobacteriaceae found in the hospital environment.
All of our isolates of K. trevisanii were indole positive and had the same profile as K. oxytoca, as determined by using the API 20E gallery. However, the API 20EC gallery readily distinguished K. trevisanii from K. oxytoca; most K. oxytoca strains ferment both dulcitol and melezitose (83% and 52%, respectively, compared with 25% and 1% for K. trevisanii). Differentiation was even more clear-cut when the carbon substrate assimilation tests were used.
The main characteristics distinguishing K. trevisanii from K. oxytoca and K. pneumoniae are listed in Table 3 (4, 6, 8) . All of the strains of the present study were indole-positive variants, but, as shown in Table 3 , there were also indolenegative variants.
The 
